- Record: found
- Abstract: not found
- Article: not found
An Open-Label Pilot Study to Evaluate the Safety and Efficacy of ADCT-301 in Patients with Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Myeloproliferative Neoplasms
Read this article at
ScienceOpen
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.